Adults at High Risk for HIV Not Testing as Often as Recommended

Adults at High Risk for HIV Not Testing as Often as Recommended

Only about 60% of U.S. adults with recent HIV-related risk behaviors were ever tested for the virus, and those high-risk individuals who have been tested are not getting tested as frequently as recommended, researchers found. A total of 62.2% of adults with HIV-risk behaviors in the last 12 months reported being ever tested for HIV, […]

Liberia: HIV Drugs Shortage Hits Liberia – Aids Commission Boss Alarms

Liberia: HIV Drugs Shortage Hits Liberia – Aids Commission Boss Alarms

By Darlington Porkpa The lives of over 35,000 people living with HIV and AIDS are being put at serious risk as the country runs out of antiretroviral (ARVs) drugs, a drug given to people living with HIV and AIDS to help fight infections. The chilling revelation was made by the Acting Head of Liberia’s AIDS […]

Short-Term Limited Duration Plans and HIV

Short-Term Limited Duration Plans and HIV

Key Findings/Points While short-term limited duration (STLD) insurance policies, which provide temporary insurance to those with coverage gaps, have long been available, the Trump Administration is seeking to promote their use and expand their availability. STLDs are exempt from ACA requirements prohibiting medical underwriting, pre-existing condition exclusions, and other protections. While not expected to cover […]

FDA Will Waive User Fees for Innovative HIV Drugs

FDA Will Waive User Fees for Innovative HIV Drugs

June 20, 2018 By Jacquie Lee Drug manufacturers that make medications to fight HIV can circumvent certain FDA fees if the drugs are innovative and the agency’s fees would prevent the drugs from ever being released. The Food and Drug Administration charges certain drugmakers administrative fees called user fees, which the agency uses as a […]

Encouraging results for GSK two-drug HIV treatment

21 June 2018 Consumer GSK, together with other companies, has been trying to find alternative treatments for HIV so that patients can take fewer drugs and take them less frequently. Scientists believe taking fewer medicines will result in fewer side effects, in addition to making life easier for patients. GSK’s […]

GSK takes on Gilead in fight for dominance in HIV drugs

GSK takes on Gilead in fight for dominance in HIV drugs

London — GlaxoSmithKline (GSK) is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference in July by showcasing detailed results from its new two-drug treatment. The drug makers are touting rival strategies for fighting the AIDS virus, with GSK betting that a shift to using two […]

Nigeria: National Assembly Budget Cuts to Stifle Vaccines, HIV Drugs

Nigeria: National Assembly Budget Cuts to Stifle Vaccines, HIV Drugs

By Judd-Leonard Okafor A total of N7.45 billion has been cut from funds allocated for strategic interventions in health care, after lawmakers adjusted portions of the 2018 Budget signed into law on Wednesday. The funding was to pay to upgrade of some federal hospitals, transport and cold-chain storage of vaccines, and payment for anti-retroviral drugs […]

Increase in drug overdoses this week: HIV North Society

Increase in drug overdoses this week: HIV North Society

The HIV North Society is warning the public about an increase in overdoses this week in Grande Prairie.  Johnny Fortune, part of the Harm Reduction Team, says they have had days with multiple drug poisonings which isn’t usually what they expect. On Wednesday, June 20, they responded to four between 9 a.m. and noon.  “We […]

Global HIV Epidemiology and Patient Flow Analysis 2018 – ResearchAndMarkets.com

Global HIV Epidemiology and Patient Flow Analysis 2018 – ResearchAndMarkets.com

This research provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of HIV derived from epidemiological analysis, patients diagnosed with HIV, and patients treated with a drug therapy. The research study helps executives estimate HIV market potential, assess unmet […]

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Strategies to reduce new HIV infections span multifaceted efforts, including safe-sex counseling, voluntary medical male circumcision, treatment as prevention, and pre- (PrEP) and postexposure prophylaxis. PrEP entails the use of antiretroviral (ARV) drugs prophylactically by HIV-negative individuals at risk of infection to thwart acquisition of the virus. In 2012, the US Food and Drug Administration […]

1 2 3 39